Graduate School
PhD, Penn State College of Medicine - 2012
Fellowships
Cancer Research Training Award (CRTA)
Laboratory of Human Carcinogenesis, National Cancer Institute/NIH
Hien T. Dang, PhD
J. Wallace Davis and Gail G. Davis Chair in Surgery
Vice Chair for Research
Director, Cancer Genomics Program, Sidney Kimmel Comprehensive Cancer Center
Contact Information
J. Wallace Davis and Gail G. Davis Chair in Surgery
Vice Chair for Research
Director, Cancer Genomics Program, Sidney Kimmel Comprehensive Cancer Center
Education
Publications
- VDAC2 and Bak scarcity in liver mitochondria enables targeting hepatocarcinoma while sparing hepatocytes
- Advances in Immunotherapy in Hepatocellular Carcinoma
- Correction to: Stiff matrix induces exosome secretion to promote tumour growth (Nature Cell Biology, (2023), 25, 3, (415-424), 10.1038/s41556-023-01092-1)
- Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
- Stiff matrix induces exosome secretion to promote tumour growth
Awards
- Early Career Investigator Award for Distinguished Achievement in Biomedical Research, SKMC 2024
- Biden Cancer Moonshot Award, National Cancer Institute/NIH 2023
- Director’s Award of Merit, National Cancer Institute/NIH
- Director’s Innovation Award, National Cancer Institute/NIH
Research Interests
Primary liver cancer (PLC) is the 2nd most common cause of cancer-related death worldwide with the fastest rising incidence and mortality in the United States.
Our lab is interested in identifying disease-acquired functions of RNA binding proteins (RBPs), and in parallel, exploit such mechanisms as actionable biomarkers or drug targets to improve diagnosis for PLC patients.
Our lab utilizes bioinformatics and bench science spanning from functional genomics, translational science, molecular epidemiology, RNA biology, cancer biology, and animal models to investigate the oncogenic roles of RBPs in PLC.
To learn more, go to Dang Laboratory